CENTEK

000931
3.314.89% ( -0.17 )
Delay Closed: Nov 20, 15:00:00

Profile

About

CENTEK
CENTEK
000931.SZ

Beijing Centergate Technologies (holding) Co., Ltd. engages in the production and sale of topical reagents, tablets, injections in China. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Naltrexone Hydrochloride tablets and injections to block the pharmacological effects of exogenous opioids; Acetaminophen and oxycodone tablets and injections for the treatment of moderate to severe pain; tramadol hydrochloride tablets and injections to treat pain in adults; aprolol hydrochloride for the treatment of hypertension, angina pectoris, tachycardia-induced arrhythmia, and tremor; buspirone hydrochloride tablets to treat various anxiety disorders; oxycodone hydrochloride extended-release tablets; and Ambroxol hydrochloride injection for the treatment of acute exacerbations of chronic bronchitis, wheezing bronchitis, and bronchial asthma. It also provides Febuxostat tablets for the treatment of hyperuricemia; Bromhexine Hydrochloride injection to treat asthma, bronchiectasis, and silicosis; Metoprolol succinate raw material; Bisoprolol Amlodipine tablets for hypertension; Sitagliptin/Metformin tablets are used for type 2 diabetes patients; Bisoprolol fumarate tablets for the treatment of hypertension, coronary, and artery diseases; and Tropanestone mesylate injection for the treatment of nausea and vomiting.

Profile

Company Name
Beijing Centergate Technologies (holding) Co., Ltd.
Market
SZSE
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management